ELAFIBRANOR | N218860 | IPSEN BIOPHARMACEUTICALS INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 11185519 | Mar 30, 2037 | — | — | — | — | |
| 11331292 | Mar 30, 2037 | — | — | — | — | |
| 11850223 | Mar 30, 2037 | — | — | — | — | |
| 11857523 | Mar 30, 2037 | — | — | — | — | |
| 12233038 | Mar 30, 2037 | — | — | — | — | |
| 12295927 | Mar 30, 2037 | — | — | — | — | |
| 12295928 | Mar 30, 2037 | — | — | — | — | |
| 12310935 | Mar 30, 2037 | — | — | — | — | |
| 12589086 | Mar 30, 2037 | — | — | — | — | |
| 12673035Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Mar 5, 2044 | — | — | Yes | — |
| Code | Date | Status |
|---|---|---|
| NCE | Jun 10, 2029 | Active |
| ODE-486 | Jun 10, 2031 | Active |